InvestorsHub Logo
Followers 283
Posts 1162
Boards Moderated 0
Alias Born 10/04/2020

Re: UncleBilly post# 30762

Friday, 10/09/2020 12:24:18 AM

Friday, October 09, 2020 12:24:18 AM

Post# of 198610
Great post! I totally agree with the excellent perspective you provided.

Yes, I definitely discern this Company merged is way under-valued especially when one considers the exclusive Patent they own on their combined technologies and the multiple infectious disease viral vaccine applications associated with it.

Well established BigPharma players could cut a deal with Enz-BioClonetics to mass produce their drug for immediate commercial use in the near future, like you said, by licensing their Patent which by itself is worth Mega-Millions in immediate royalty revenues that will show up in the Quarterly Earnings Reports reflected in its Market Cap.

This would be a game changer and it's definitely the "fast-track" approach that could transform their company literally over night post-merge into a major player in BigPharma! Many doors will open for them as a result.

I believe the Merger itself has the potential to kick-up the PPS into the DOLLAR trading range but still on the OTC.

If fast track commercialization begins via BigPharma partners, the PPS will rapidly rise with transition to one of the major exchanges and its Market Cap will explode!

How long that will take is anyone's guess.